Journal of Antimicrobial Chemotherapy (1995) 36, 827-831
© 1995 The British Society for Antimicrobial Chemotherapy
brief-report |
Inhibition of Helicobacter pylori growth by 4-hydroxy-2-alkyl-quinolines produced by Pseudomonas aeruginosa


aDepartment of Infectious Diseases and Bacteriology bDepartment of Clinical Pharmacology, Royal Postgraduate Medical School Du Cane Road, London W12 ONN, UK
Received 22 November 1994; returned 8 March 1995; accepted 12 June 1995
*Present address: Redbridge Health Care, King Georges Hospital, Barley Lane, Goodmayes, Essex IG3 8YB, UK.
4-Hydroxy-2-alkylquinolines produced by Pseudomonas aeruginosa can inhibit the growth of both metronidazole-sensitive and resistant strains of Helicobacter pylori in vitro. The MIC of one analogue, 4-hydroxy-2-heptylquinoline, was determined by agar plate incorporation as 0.10.5 mg/L which compares favourably with other anti-helicobacter agents.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
M. G. Domínguez-Bello, N. Reyes, A. Teppa-Garrán, and R. Romero Interference of Pseudomonas Strains in the Identification of Helicobacter pylori J. Clin. Microbiol., February 1, 2000; 38(2): 937 - 937. [Full Text] |
||||
